MRNA Moderna, Inc. Stock Quote

MRNA [NASD]

Index	S&P 500	P/E	18.84	EPS (ttm)	16.28	Insider Own	1.90%	Shs Outstand	404.00M	Perf Week	-6.95%
Market Cap	122.24B	Forward P/E	11.65	EPS next Y	26.32	Insider Trans	-15.21%	Shs Float	366.80M	Perf Month	-11.33%
Income	7.06B	PEG	1.12	EPS next Q	6.86	Inst Own	61.20%	Short Float	3.97%	Perf Quarter	-26.39%
Sales	11.83B	P/S	10.33	EPS this Y	-26.10%	Inst Trans	5.86%	Short Ratio	1.06	Perf Half Y	39.69%
Book/sh	25.06	P/B	12.24	EPS next Y	2.18%	ROA	49.50%	Target Price	304.92	Perf Year	95.04%
Cash/sh	22.35	P/C	13.73	EPS next 5Y	16.80%	ROE	121.60%	52W Range	102.66 - 497.49	Perf YTD	193.60%
Dividend	-	P/FCF	10.74	EPS past 5Y	-	ROI	-28.40%	52W High	-38.35%	Beta	-
Dividend %	-	Quick Ratio	1.30	Sales past 5Y	-	Gross Margin	85.90%	52W Low	198.77%	ATR	26.33
Employees	1300	Current Ratio	1.30	Sales Q/Q	6398.50%	Oper. Margin	64.30%	RSI (14)	51.76	Volatility	7.98% 6.98%
Optionable	Yes	Debt/Eq	0.05	EPS Q/Q	-	Profit Margin	59.70%	Rel Volume	0.92	Prev Close	301.49
Shortable	Yes	LT Debt/Eq	0.02	Earnings	Nov 04 BMO	Payout	0.00%	Avg Volume	13.72M	Price	306.72
Recom	2.70	SMA20	13.38%	SMA50	-2.88%	SMA200	17.31%	Volume	12,620,589	Change	1.73%

Nov-09-21

Initiated

Wolfe Research

Outperform

$304

Oct-22-21

Initiated

Deutsche Bank

Sell

$250

Oct-15-21

Upgrade

Piper Sandler

Neutral → Overweight

$445

Aug-06-21

Downgrade

Piper Sandler

Overweight → Neutral

$246 → $445

Aug-06-21

Downgrade

Oppenheimer

Outperform → Perform

Jul-15-21

Reiterated

Jefferies

Hold

$170 → $250

Feb-01-21

Downgrade

BofA Securities

Neutral → Underperform

Dec-16-20

Downgrade

Morgan Stanley

Overweight → Equal-Weight

$150

Dec-16-20

Downgrade

Jefferies

Buy → Hold

$90 → $150

Dec-09-20

Downgrade

Needham

Buy → Hold

Nov-23-20

Initiated

Wells Fargo

Equal Weight

$92

Nov-17-20

Downgrade

BMO Capital Markets

Outperform → Market Perform

$109

Sep-08-20

Downgrade

SVB Leerink

Mkt Perform → Underperform

$58 → $41

Jul-23-20

Initiated

SVB Leerink

Mkt Perform

Jul-20-20

Downgrade

JP Morgan

Overweight → Neutral

$89

Jul-13-20

Initiated

Jefferies

Buy

$90

Jun-30-20

Initiated

Argus

Buy

$80

Jun-08-20

Initiated

Barclays

Overweight

$68

Apr-30-20

Initiated

BMO Capital Markets

Outperform

$83

Mar-05-20

Downgrade

BofA/Merrill

Buy → Neutral

$32

Dec-04-21 06:55AM	Could Moderna and AstraZeneca's mRNA Heart Failure Drug Candidate Be a Winner? Motley Fool
06:30AM	1 Green Flag for Moderna in 2022, and 1 Red Flag Motley Fool
05:57AM	Guess who pays for all those millions of COVID-19 vaccines Yahoo Finance
05:15AM	Moderna Has Tripled This Year But You Can Get Its Stock for $1 Motley Fool
Dec-03-21 07:06PM	Moderna, Twitter, Kroger: Stocks That Defined the Week The Wall Street Journal
07:00PM	Omicron Is a Big Unknown. Whats Ahead, According to a Key FDA Official. Barrons.com
04:15PM	The New 'Mutant Virus' Signals A Need For Annual Shots: BioNTech CEO Investor's Business Daily
04:13PM	Doctor explains what we know about the Omicron variant's spread Yahoo Finance Video
03:22PM	Novavax (NVAX) Starts Developing Omicron-Specific COVID Jab Zacks
02:48PM	Omicron-fuelled volatility deals hedge funds worst monthly return since March 2020 Reuters
02:38PM	Omicron-fuelled volatility deals hedge funds worst monthly return since March 2020 Reuters
02:35PM	A new study finds that most COVID-19 boosters strengthen immunity, though there is no winning shot MarketWatch
12:34PM	Vaccine Stocks Ask The Unthinkable: What Happens If Today's Covid Shots Fail? Investor's Business Daily
11:55AM	COVID: We need to stop wearing cloth masks and go to N95s for all, expert says Yahoo Finance Video
11:45AM	WHO Says Don't Panic Over Omicron, Delta Still Dominant TheStreet.com
09:20AM	COVID-19 Vaccine & Drug Makers Gear Up to Fight Omicron Zacks
07:31AM	Here's What Vaccine CEOs Have to Say About the Omicron Variant Motley Fool
06:58AM	UPDATE 1-UK study finds mRNA COVID-19 vaccines provide biggest booster impact Reuters
04:56AM	Moderna Stock Climbs; FDA Seeks Rapid Review of Omicron Vaccines TheStreet.com
Dec-02-21 06:30PM	UK study finds mRNA COVID-19 vaccines provide biggest booster impact Reuters
05:29PM	U.S. administers 464.4 mln doses of COVID-19 vaccines - CDC Reuters
04:00PM	3 Stocks to Buy for the New COVID Variant Motley Fool
02:40PM	'Investors need to take a longer term perspective' amid market volatility, strategist says Yahoo Finance Video
02:23PM	Biden's new plan COVID-19 plan includes 'two new points,' analyst explains Yahoo Finance Video
02:19PM	President Biden outlines steps to combat COVID-19 in winter Yahoo Finance Video
01:42PM	Doctor: U.S. needs to prepare for a potential perfect storm' between Omicron variant and winter Yahoo Finance Video
01:13PM	Why Novavax Stock Is in Retreat Mode Today Motley Fool
11:39AM	Fauci says changing fully vaccinated definition to include boosters on the table MarketWatch
11:31AM	Omicron variant: Areas with high vaccination rates will just see this as a ripple, not a surge, doctor says Yahoo Finance Video
11:11AM	COVID: Second Omicron variant case identified in Minnesota Yahoo Finance Video
10:54AM	COVID: The Omicron variant doubles down on the importance of booster shots, doctor says Yahoo Finance Video
10:43AM	Coronavirus update: Biden administration plans for winter COVID-19 surge Yahoo Finance
09:53AM	Modernas Patent Issues Highlight Uncertainty for a Vaccine Star Barrons.com
09:08AM	U.K. to buy an additional 60 million doses of Moderna's COVID-19 vaccine MarketWatch
06:40AM	3 Hard Facts Moderna and Pfizer Investors Need to Know About the Omicron Variant Motley Fool
06:15AM	Why Moderna's Canada Booster Win Is Important Motley Fool
06:00AM	Influencers with Andy Serwer: Geoff Martha Yahoo Finance Video
Dec-01-21 09:28PM	Moderna Announces Supply Agreement with the UK for Additional 60 Million Doses of Modernas COVID-19 Vaccine in 2022 and 2023 Business Wire -11.87%
06:22PM	Why Moderna Stock Plunged Today Motley Fool
05:44PM	U.S. administers 462.3 mln doses of COVID-19 vaccines - CDC Reuters
05:30PM	UK agrees deals for 114 million more Moderna and Pfizer COVID-19 doses Reuters
04:11PM	First U.S. Case of Omicron Variant Confirmed in California Bloomberg
03:33PM	COVID SCIENCE-Brain problems found in 1% of hospitalized COVID-19 patients; real-world data shows Moderna vaccine highly effective Reuters
02:51PM	Moderna exec says company could have Omicron booster ready in March Reuters
02:43PM	CDC identifies the first case of Omicron variant in the U.S. Yahoo Finance Video
02:36PM	Inflation is the biggest risk for markets going into 2022: Strategist Yahoo Finance Video
01:54PM	We still have a lot more work to do, former White House vaccinations coordinator says Yahoo Finance Video
12:20PM	Why Arbutus Biopharma Is Rocketing Higher Today Motley Fool
11:58AM	Moderna Stock Tanks After Losing a Patent Dispute. Heres What Comes Next. Barrons.com
11:37AM	Omicron variant: The Biden administration plans to tighten restrictions for travelers to the U.S. Yahoo Finance Video
09:49AM	Moderna's (MRNA) Stock Falls on Omicron Variant Concerns Zacks
08:21AM	Dow Jones Futures Signal Market Rally After Powell Sell-Off; 3 Tesla Rivals Report Strong Sales Investor's Business Daily
08:13AM	Omicron: Doctor details key questions about new COVID-19 variant Yahoo Finance
07:22AM	Arbutus Shares Rise Moderna's Fall After Patent Appeal Denied Investing.com
06:40AM	2 Stocks to Buy If You Are Worried About the New Coronavirus Variant Motley Fool
06:03AM	Will Moderna Become the Next Big Meme Stock? Motley Fool
06:00AM	Is This Latecomer a Better Buy Than Moderna and Pfizer? Motley Fool
05:00AM	Medtronic CEO on partnering with Elon Musk at the height of COVID-19 Yahoo Finance Video
Nov-30-21 05:26PM	Omicron threat in the U.S: 'We can presume it's here,' physician says Yahoo Finance Video
05:20PM	U.S. administers 460.7 mln doses of COVID-19 vaccines - CDC Reuters
04:21PM	Dow Jones Dives As Powell Gives This Inflation Warning; Covid Vaccine Fear Hits Moderna; Apple, Tesla Stock Gain Investor's Business Daily
04:20PM	Stocks Had Another Ugly Day. They Couldnt Shake Off Omicronor Powell. Barrons.com
04:15PM	Adagio Continues Its Run As Biotech Stocks Moderna, BioNTech Dive On Omicron Threat Investor's Business Daily
04:14PM	Is Moderna Stock A Buy Or Sell As The Omicron Threat Buoys Shares? Investor's Business Daily
03:23PM	Oil prices suffer steepest monthly decline since March 2020 MarketWatch
03:10PM	WRAPUP 12-Officials offer vaccine reassurance; WHO advises against travel bans Reuters
03:03PM	Analysis: As Omicron plays havoc with markets, shares of vaccine makers surge Reuters
02:55PM	Column: Raking in profits, Moderna denies government scientists credit for the COVID vaccine LA Times
02:53PM	Oil futures suffer largest monthly loss since March 2020 MarketWatch
02:40PM	Gold settles lower on Powell testimony amid concerns about omicron MarketWatch
02:26PM	Moderna CEO says vaccines likely less effective against Omicron COVID-19 variant Yahoo Finance Video
02:14PM	Moderna: The Best Covid-19 Vaccine Maker Around, Says Analyst TipRanks
02:10PM	Omicron: 'Time will tell' as we learn more about transmissibility and risk, doctor explains Yahoo Finance Video
02:08PM	'The market doesn't like an information vacuum, and now we have two,' strategist says Yahoo Finance Video
01:54PM	Gold futures settle lower for the session and month MarketWatch
12:57PM	Moderna ETFs Rallying on COVID-19 Vaccine News to Combat Omicron Zacks
12:20PM	Dow Jones Dives 650 Points After Fed's Powell Comments; Omicron Fears Spread Investor's Business Daily
11:13AM	Pre-Markets Down on Omicron Fears Zacks
10:44AM	WHO urges calm approach to omicron variant of COVID, warns travel restrictions may undermine surveillance and tracking MarketWatch
10:37AM	Moderna (MRNA) Rallies on Booster Hopes Amid Omicron Concerns Zacks
10:10AM	We cant have countries lingering at 10%' COVID-19 vaccination, Columbia professor explains Yahoo Finance Video
10:00AM	Dow Jones Sells Off As Moderna CEO Expects Less Effective Vaccines For Omicron Variant Investor's Business Daily
10:00AM	9 Words From Moderna's CEO That Could Signal a Boost in Vaccine Orders Motley Fool
09:59AM	Stocks fall as investors try to gauge Omicron risk, ongoing supply chain issues Yahoo Finance Video
09:59AM	TREASURIES-Yields fall to three-week lows on Omicron fears Reuters
09:48AM	Market strategist: Investors dont want to overreact amid Omicron uncertainty Yahoo Finance Video
08:33AM	Moderna Stock Slides After CEO Says Current Vaccines Will Struggle Against Omicron Barrons.com
08:11AM	The Zacks Analyst Blog Highlights: Pfizer, BioNTech, Moderna and Novavax Zacks
07:55AM	FOREX-Euro on track for biggest three-day rising streak of 2021 Reuters
06:55AM	Dont hesitate, get a COVID booster now: epidemiologist urges Yahoo Finance
06:50AM	JPMorgan Says Omicron Wont Stop the Global Equities Rally Bloomberg
06:32AM	Modernas Omicron Warning Reignites Selloff. Get Used to Volatility. Barrons.com
06:24AM	Moderna Stock Is Sliding After Its CEO Said Current Vaccines Are Likely to Struggle Against the Omicron Variant Barrons.com
05:17AM	TREASURIES-Yields fall to three-week lows as vaccine worries spook investors Reuters
05:13AM	FOREX-Euro set for biggest 3-day rising streak in 2021 Reuters
05:03AM	This is not going to be good Moderna CEO on what scientists are telling him about the omicron coronavirus variant MarketWatch
04:29AM	EMERGING MARKETS-Currencies, stocks fall on vaccine efficacy worries Reuters
04:28AM	Moderna CEO Says Current Vaccines Likely to Struggle Against Omicron Variant Barrons.com
04:09AM	European markets fall as Moderna boss says vaccine less effective against Omicron Yahoo Finance UK
03:53AM	EasyJet bookings hit by Omicron variant as losses total £1bn Yahoo Finance UK

Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a total of 24 development programs in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted and cell surface therapeutics, and systemic intracellular therapeutics. The company has strategic alliances with AstraZeneca PLC, Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited, the Biomedical Advanced Research and Development Authority, the Defense Advanced Research Projects Agency, the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, the Coalition for Epidemic Preparedness Innovations, and Bill & Melinda Gates Foundation. Moderna, Inc. also has collaborations with Lonza Ltd. for the manufacture of COVID-19 vaccine; and Catalent Inc., Laboratorios Farmaceuticos Rovi, S.A., Recipharm, and Lonza Group for fill-finish manufacturing of its COVID-19 vaccine candidate, as well as Aldevron, LLC for supporting COVID-19 vaccine and additional programs in company's clinical development pipeline. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bancel Stephane	Chief Executive Officer	Dec 02	Sale	301.29	10,000	3,012,900	7,124,880	Dec 03 04:59 PM
Andres Juan	See remarks	Dec 01	Option Exercise	12.21	5,000	61,050	5,000	Dec 03 05:04 PM
Bancel Stephane	Chief Executive Officer	Dec 01	Sale	329.91	9,000	2,969,190	5,944,535	Dec 03 04:59 PM
Andres Juan	See remarks	Dec 01	Sale	329.91	5,000	1,649,550	0	Dec 03 05:04 PM
Andres Juan	See remarks	Nov 29	Option Exercise	12.21	5,000	61,050	5,000	Nov 30 04:09 PM
Andres Juan	See remarks	Nov 29	Sale	370.38	5,000	1,851,900	0	Nov 30 04:09 PM
Andres Juan	See remarks	Nov 26	Option Exercise	12.21	5,000	61,050	5,000	Nov 30 04:09 PM
Andres Juan	See remarks	Nov 26	Sale	319.62	5,000	1,598,100	0	Nov 30 04:09 PM
Bancel Stephane	Chief Executive Officer	Nov 26	Sale	319.62	10,000	3,196,200	7,134,880	Nov 30 04:12 PM
Andres Juan	See remarks	Nov 24	Option Exercise	12.21	5,000	61,050	5,000	Nov 26 02:08 PM
Bancel Stephane	Chief Executive Officer	Nov 24	Sale	273.01	9,000	2,457,090	5,940,868	Nov 26 01:59 PM
Andres Juan	See remarks	Nov 24	Sale	273.01	5,000	1,365,050	0	Nov 26 02:08 PM
Hoge Stephen	President	Nov 23	Option Exercise	4.29	15,000	64,400	1,624,597	Nov 26 02:20 PM
Hoge Stephen	President	Nov 23	Sale	275.52	15,000	4,132,772	1,609,597	Nov 26 02:20 PM
Andres Juan	See remarks	Nov 22	Option Exercise	13.55	15,000	203,250	15,000	Nov 23 06:16 PM
Andres Juan	See remarks	Nov 22	Sale	268.18	15,000	4,022,700	0	Nov 23 06:16 PM
Andres Juan	See remarks	Nov 19	Option Exercise	12.21	5,000	61,050	5,000	Nov 23 06:16 PM
Andres Juan	See remarks	Nov 19	Sale	265.71	5,000	1,328,550	0	Nov 23 06:16 PM
Bancel Stephane	Chief Executive Officer	Nov 18	Sale	245.89	10,000	2,458,900	7,144,880	Nov 19 04:09 PM
Andres Juan	See remarks	Nov 17	Option Exercise	12.21	5,000	61,050	5,000	Nov 19 04:15 PM
Bancel Stephane	Chief Executive Officer	Nov 17	Sale	234.57	9,000	2,111,130	5,953,868	Nov 19 04:09 PM
Andres Juan	See remarks	Nov 17	Sale	234.57	5,000	1,172,850	0	Nov 19 04:15 PM
Andres Juan	See remarks	Nov 15	Option Exercise	12.21	5,000	61,050	5,000	Nov 16 04:23 PM
Hoge Stephen	President	Nov 15	Option Exercise	4.29	15,000	64,400	1,624,597	Nov 16 04:25 PM
Andres Juan	See remarks	Nov 15	Sale	231.01	5,000	1,155,050	0	Nov 16 04:23 PM
Hoge Stephen	President	Nov 15	Sale	231.01	15,000	3,465,150	1,609,597	Nov 16 04:25 PM
Andres Juan	See remarks	Nov 12	Option Exercise	12.21	5,000	61,050	5,000	Nov 16 04:23 PM
Hoge Stephen	President	Nov 12	Option Exercise	10.90	5,000	54,500	1,614,597	Nov 16 04:25 PM
Andres Juan	See remarks	Nov 12	Sale	225.86	5,000	1,129,300	0	Nov 16 04:23 PM
Hoge Stephen	President	Nov 12	Sale	225.86	5,000	1,129,300	1,609,597	Nov 16 04:25 PM
Bancel Stephane	Chief Executive Officer	Nov 11	Sale	227.67	10,000	2,276,700	7,154,880	Nov 12 04:07 PM
Andres Juan	See remarks	Nov 10	Option Exercise	12.21	5,000	61,050	5,000	Nov 12 04:16 PM
Bancel Stephane	Chief Executive Officer	Nov 10	Sale	230.00	9,000	2,070,000	5,996,868	Nov 12 04:07 PM
Andres Juan	See remarks	Nov 10	Sale	230.00	5,000	1,150,000	0	Nov 12 04:16 PM
Andres Juan	See remarks	Nov 08	Option Exercise	13.55	15,000	203,250	15,000	Nov 09 04:36 PM
Andres Juan	See remarks	Nov 08	Sale	233.13	15,000	3,496,950	0	Nov 09 04:36 PM
Andres Juan	See remarks	Nov 05	Option Exercise	12.21	5,000	61,050	5,000	Nov 09 04:36 PM
Andres Juan	See remarks	Nov 05	Sale	240.00	5,000	1,200,000	0	Nov 09 04:36 PM
Bancel Stephane	Chief Executive Officer	Nov 04	Sale	295.50	10,000	2,955,000	7,164,880	Nov 05 05:04 PM
Hoge Stephen	President	Nov 03	Option Exercise	0.99	10,000	9,900	1,619,597	Nov 04 04:43 PM
Andres Juan	See remarks	Nov 03	Option Exercise	12.21	5,000	61,050	5,000	Nov 05 05:09 PM
Hoge Stephen	President	Nov 03	Sale	350.00	10,000	3,500,000	1,609,597	Nov 04 04:43 PM
Bancel Stephane	Chief Executive Officer	Nov 03	Sale	350.00	9,000	3,150,000	6,009,868	Nov 05 05:04 PM
Andres Juan	See remarks	Nov 03	Sale	350.00	5,000	1,750,000	0	Nov 05 05:09 PM
Hoge Stephen	President	Nov 02	Option Exercise	0.99	10,000	9,900	1,619,597	Nov 04 04:43 PM
Hoge Stephen	President	Nov 02	Sale	338.54	10,000	3,385,400	1,609,597	Nov 04 04:43 PM
Andres Juan	See remarks	Nov 01	Option Exercise	12.21	5,000	61,050	5,000	Nov 02 04:16 PM
Andres Juan	See remarks	Nov 01	Sale	335.00	5,000	1,675,000	0	Nov 02 04:16 PM
Andres Juan	See remarks	Oct 29	Option Exercise	12.21	5,000	61,050	5,000	Nov 02 04:16 PM
Andres Juan	See remarks	Oct 29	Sale	344.49	5,000	1,722,450	0	Nov 02 04:16 PM
Bancel Stephane	Chief Executive Officer	Oct 28	Sale	343.74	10,000	3,437,400	7,174,880	Oct 29 04:36 PM
Andres Juan	See remarks	Oct 27	Option Exercise	12.21	5,000	61,050	5,000	Oct 29 04:32 PM
Andres Juan	See remarks	Oct 27	Sale	344.25	5,000	1,721,250	0	Oct 29 04:32 PM
Bancel Stephane	Chief Executive Officer	Oct 27	Sale	344.25	9,000	3,098,250	6,022,868	Oct 29 04:36 PM
Hoge Stephen	President	Oct 25	Option Exercise	5.95	20,000	118,900	1,629,597	Oct 26 06:00 PM
Andres Juan	See remarks	Oct 25	Option Exercise	12.23	15,000	183,508	15,000	Oct 26 05:13 PM
Hoge Stephen	President	Oct 25	Sale	331.80	20,000	6,636,097	1,609,597	Oct 26 06:00 PM
Andres Juan	See remarks	Oct 25	Sale	327.36	15,000	4,910,400	0	Oct 26 05:13 PM
Andres Juan	See remarks	Oct 22	Option Exercise	12.21	5,000	61,050	5,000	Oct 26 05:13 PM
Andres Juan	See remarks	Oct 22	Sale	333.00	5,000	1,665,000	0	Oct 26 05:13 PM
Bancel Stephane	Chief Executive Officer	Oct 21	Sale	337.00	10,000	3,370,000	7,184,880	Oct 22 05:23 PM
Andres Juan	See remarks	Oct 20	Option Exercise	12.21	5,000	61,050	5,000	Oct 22 05:39 PM
Bancel Stephane	Chief Executive Officer	Oct 20	Sale	333.90	9,000	3,005,100	6,035,868	Oct 22 05:23 PM
Andres Juan	See remarks	Oct 20	Sale	333.90	5,000	1,669,500	0	Oct 22 05:39 PM
Andres Juan	See remarks	Oct 18	Option Exercise	12.21	5,000	61,050	5,000	Oct 19 04:11 PM
Andres Juan	See remarks	Oct 18	Sale	322.26	5,000	1,611,300	0	Oct 19 04:11 PM
Andres Juan	See remarks	Oct 15	Option Exercise	12.21	5,000	61,050	5,000	Oct 19 04:11 PM
Andres Juan	See remarks	Oct 15	Sale	341.25	5,000	1,706,250	0	Oct 19 04:11 PM
Bancel Stephane	Chief Executive Officer	Oct 14	Sale	329.00	10,000	3,290,000	7,194,880	Oct 15 04:05 PM
Hoge Stephen	President	Oct 13	Option Exercise	4.29	15,000	64,400	1,624,597	Oct 14 04:10 PM
Andres Juan	See remarks	Oct 13	Option Exercise	12.21	5,000	61,050	5,000	Oct 14 04:21 PM
SAGAN PAUL	Director	Oct 13	Sale	314.90	2,250	708,525	14,951	Oct 15 04:03 PM
Bancel Stephane	Chief Executive Officer	Oct 13	Sale	314.90	9,000	2,834,100	6,048,868	Oct 15 04:05 PM
Hoge Stephen	President	Oct 13	Sale	314.90	15,000	4,723,500	1,609,597	Oct 14 04:10 PM
Andres Juan	See remarks	Oct 13	Sale	314.90	5,000	1,574,500	0	Oct 14 04:21 PM
Hoge Stephen	President	Oct 12	Option Exercise	10.90	5,000	54,500	1,614,597	Oct 14 04:10 PM
Hoge Stephen	President	Oct 12	Sale	313.22	5,000	1,566,100	1,609,597	Oct 14 04:10 PM
Andres Juan	See remarks	Oct 11	Option Exercise	12.21	15,000	183,150	15,000	Oct 12 04:16 PM
Andres Juan	See remarks	Oct 11	Sale	300.00	15,000	4,500,000	0	Oct 12 04:16 PM
Andres Juan	See remarks	Oct 08	Option Exercise	12.21	5,000	61,050	5,000	Oct 12 04:16 PM
Andres Juan	See remarks	Oct 08	Sale	310.44	5,000	1,552,200	0	Oct 12 04:16 PM
Bancel Stephane	Chief Executive Officer	Oct 07	Sale	295.00	10,000	2,950,000	7,204,880	Oct 08 04:14 PM
Andres Juan	See remarks	Oct 06	Option Exercise	12.21	5,000	61,050	5,000	Oct 08 04:18 PM
Bancel Stephane	Chief Executive Officer	Oct 06	Sale	318.23	9,000	2,864,070	6,061,868	Oct 08 04:14 PM
Andres Juan	See remarks	Oct 06	Sale	318.23	5,000	1,591,150	0	Oct 08 04:18 PM
Hoge Stephen	President	Oct 04	Option Exercise	0.99	20,000	19,800	1,629,597	Oct 06 04:09 PM
Andres Juan	See remarks	Oct 04	Option Exercise	12.21	5,000	61,050	5,000	Oct 05 04:12 PM
Hoge Stephen	President	Oct 04	Sale	307.54	20,000	6,150,800	1,609,597	Oct 06 04:09 PM
Andres Juan	See remarks	Oct 04	Sale	307.54	5,000	1,537,700	0	Oct 05 04:12 PM
Andres Juan	See remarks	Oct 01	Option Exercise	12.21	5,000	61,050	5,000	Oct 05 04:12 PM
Andres Juan	See remarks	Oct 01	Sale	359.00	5,000	1,795,000	0	Oct 05 04:12 PM
Bancel Stephane	Chief Executive Officer	Sep 30	Sale	381.82	10,000	3,818,200	7,214,880	Oct 01 08:50 AM
Andres Juan	See remarks	Sep 29	Option Exercise	12.21	5,000	61,050	5,000	Oct 01 08:53 AM
Bancel Stephane	Chief Executive Officer	Sep 29	Sale	393.44	9,000	3,540,960	6,074,868	Oct 01 08:50 AM
Andres Juan	See remarks	Sep 29	Sale	393.44	5,000	1,967,200	0	Oct 01 08:53 AM
Andres Juan	See remarks	Sep 27	Option Exercise	12.21	15,000	183,150	15,000	Sep 28 04:22 PM
Andres Juan	See remarks	Sep 27	Sale	429.38	15,000	6,440,700	0	Sep 28 04:22 PM
Hoge Stephen	President	Sep 24	Option Exercise	10.90	5,000	54,500	1,614,597	Sep 27 04:11 PM
Andres Juan	See remarks	Sep 24	Option Exercise	12.21	5,000	61,050	5,000	Sep 28 04:22 PM
Hoge Stephen	President	Sep 24	Sale	448.04	5,000	2,240,200	1,609,597	Sep 27 04:11 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience